Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS)

Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS)

Abstract There is a pressing clinical need for thrombolytic agents that can effectively disaggregate arterial thrombi in acute ischemic stroke without significantly increasing the risk of bleeding. This pilot study aimed to investigate the safety and efficacy of N-acetylcysteine (NAC) as an adjuncti...

Full description

Bibliographic Details
Main Authors: Snigdha Komakula, Rohit Bhatia, Akhil Sahib, Ashish Upadhyay, Leve Joseph S, Ajay Garg, Vishnu V Y, Awadh Kishor Pandit, Deepti Vibha, Mamta Bhushan Singh, Manjari Tripathi, M. V. Padma Srivastava
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-49054-9

Internet

https://doi.org/10.1038/s41598-023-49054-9

Similar Items